Back to Market Feed

Product Information

GRISEOFULVIN 125 MG/5 ML SUSP is a generic product labeled by Chartwell RX LLC, priced at $0.2519 per ML under NDC 62135096841. Its NADAC has been published 233 times since Nov 10, 2021.

FDA first approved this application on Mar 2, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GRISEOFULVIN 125 MG/5 ML SUSP

Griseofulvin (microsize)
$0.2519per ML

Strength

125 mg/5mL

Manufacturer

Chartwell RX LLC

NDC

62135096841

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GRISEOFULVIN

Approval Type

Generic (ANDA)

FDA Application

ANDA065200

FDA Approved

3/2/2005

TE Code

AB

On Market Since

3/2/2005

Pharmacological Classes

Decreased Mitosis
Microtubule Inhibition
Tubulin Inhibiting Agent

Price Statistics

The NADAC for GRISEOFULVIN 125 MG/5 ML SUSP has been published 233 times since Nov 10, 2021, and over the history we have for it it has declined 4.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2519 per ML
All-time high$0.4099 (Dec 13, 2023)
All-time low$0.2115 (Nov 17, 2021)
52-week high$0.2989
52-week low$0.2471
Median price$0.3148
Average price$0.3249
Largest weekly change-19.8% (Nov 17, 2021)
Weeks tracked233
Tracking sinceNov 10, 2021

Price History

1W

+1.2%

1M

+1.2%

3M

-1.5%

6M

-4.7%

1Y

-15.7%

3Y

-38.5%

5Y

N/A

All

-4.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Griseofulvin (microsize) market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

GRISEOFULVIN 125 MG/5 ML SUSP
Generic
00472001304•Actavis Pharma, Inc.
$0.2519
per ML
GRISEOFULVIN 125 MG/5 ML SUSP
Generic
69097036108•Cipla USA Inc.
$0.2519
per ML
GRISEOFULVIN 125 MG/5 ML SUSP
Generic
00713085004•Cosette Pharmaceuticals, Inc.
$0.3950
per ML
PACLITAXEL 300 MG/50 ML VIAL
Generic
61703034250•Hospira Inc.
$1.7700
per ML
PACLITAXEL 300 MG/50 ML VIAL
Generic
63323076350•Fresenius Kabi USA, LLC
$1.7700
per ML
PACLITAXEL 100 MG/16.7 ML VIAL
Generic
61703034222•Hospira Inc.
$1.8891
per ML
PACLITAXEL 100 MG/16.7 ML VIAL
Generic
63323076316•Fresenius Kabi USA, LLC
$1.8891
per ML
PACLITAXEL 30 MG/5 ML VIAL
Generic
61703034209•Hospira Inc.
$2.1290
per ML
GRISEOFULVIN ULTRA 125 MG TAB
Generic
00115172401•Amneal Pharmaceuticals of New York LLC
$2.7523
per EA
GRISEOFULVIN ULTRA 125 MG TAB
Generic
00781582701•Sandoz Inc.
$2.7523
per EA

Frequently asked questions

What is the NADAC price of GRISEOFULVIN 125 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for GRISEOFULVIN 125 MG/5 ML SUSP, manufactured by Chartwell RX LLC, is $0.2519 per ML (NDC 62135096841), effective Aug 19, 2026.

How has the price of GRISEOFULVIN 125 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for GRISEOFULVIN 125 MG/5 ML SUSP has declined 4.5%. It has been tracked across 233 weekly CMS publications since Nov 10, 2021.

What are the highest and lowest recorded NADAC prices for GRISEOFULVIN 125 MG/5 ML SUSP?

Since Nov 10, 2021, the NADAC for GRISEOFULVIN 125 MG/5 ML SUSP has ranged from a low of $0.2115 (Nov 17, 2021) to a high of $0.4099 (Dec 13, 2023), with a median of $0.3148 per ML.

Are there cheaper alternatives to GRISEOFULVIN 125 MG/5 ML SUSP?

No other NADAC-published product currently shares the active ingredient and strength of GRISEOFULVIN 125 MG/5 ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures GRISEOFULVIN 125 MG/5 ML SUSP?

GRISEOFULVIN 125 MG/5 ML SUSP (NDC 62135096841) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.